ArticleJournal of pharmaceutical analysis2026

Multiple gastric cancer tissue proteomic identification predicts CLU as a biomarker for anti-PD-1 immunotherapy.

Yu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.